Bone mineral density among cirrhotic patients awaiting liver transplantation

Liver Transplantation

Volumn 10, Issue 5, 2004, Pages 648-653

  Paramvir Sokhi, Rana ^a   Anantharaju, Abhinandana ^a   Kondaveeti, Ravi ^a   Creech, Steven D ^a   Islam, Khondker K ^a   Van Thiel, David H ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BONE DENSITY; BONE MINERAL; CHRONIC LIVER DISEASE; CONTROLLED STUDY; FEMALE; FEMUR NECK; HORMONE SUBSTITUTION; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LUMBAR VERTEBRA; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; OSTEOPOROSIS; POSTMENOPAUSE; PREMENOPAUSE; PREOPERATIVE PERIOD; PREVALENCE; PRIORITY JOURNAL; SEX RATIO; STATISTICAL ANALYSIS;

ADULT; BONE DENSITY; COMORBIDITY; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; OSTEOPOROSIS; PREVALENCE;

EID: 2442473384     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20104     Document Type: Article

References (27)

1. Dempster DW, Lindsay R. Pathogenesis of osteoporosis. Lancet 1993,341:797-801.
2. Ng TM, Bajjoka IE. Treatment options for osteoporosis in chronic liver disease patients requiring liver transplantation. Ann Pharmacother 1999;33:233-235.
3. Eastell R, Dickson ER, Hodgson SF, Wiesner RH, Porayko MK, Wahner HW. Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis. Hepatology 1991;14:296-300.
4. Bonkovsky HL, Hawkins M, Steinberg K, Hersh T, Galambos JT, Henderson JM, et al. Prevalence and prediction of osteopenia in chronic liver disease. Hepatology 1990;12:273-280.
5. Stellon AJ, Webb A, Compston J, Williams R. Lack of osteomalacia in chronic cholestatic liver disease. Bone 1986;7:181-185.
6. Hussaini SH, Stewart SP, Roman F, Oldroyd B, Bramley P, Simpson M, et al. Osteoporosis after liver transplantation: an overestimated risk? Gut 1995;36:A20.
7. Abdelhadi M, Eriksson SAV, Ljusk Eriksson S, Ericzon B, Nordenstrom J. Bone mineral status in end-stage liver disease and the effect of liver transplantation. Scand J Gastroenterol 1995;30: 1210-1215.
8. Diamond TH, Steil D, Lunzer M. Hepatic osteodystrophy - static and dynamic bone histomorphometry and serum bone gla-protein in 80 patients with chronic liver disease. Gastroenterology 1989;96:213-221.
9. Lindor KD. Management of osteopenia of liver disease with special emphasis on primary biliary cirrhosis. Semin Liver Dis 1993;13:367-373.
10. Conte D, Caraceni MP, Duriez J, Mandello C, Corghi E, Cesana M. Bone involvement in primary hemochromatosis and alcoholic cirrhosis. Am J Gastroenterol 1989;84:1231-1234.
11. Looker AC, Orwoll ES, Johnston CC, Jr., Lindsay RL, Wahner HW, Dunn WL, et al. Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res 1997; 12:1761-1768.
12. Diamond T, Stiel D, Lunzer M, Wilkinson M, Roche J, Posen S. Osteoporosis and skeletal fractures in chronic liver disease. Gut 1990;31:82-87.
13. Chen CC, Wang SS, Jeng FS, Lee SD. Metabolic bone disease of liver cirrhosis: is it parallel to the clinical severity of cirrhosis? J Gastroenterol Hepatol 1996;11:417-421.
14. Monegal A, Navasa M, Guanabens N, Paris P, Pons F, Martinez de Osaba MJ, et al. Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation. Calcif Tissue Int 1997;60:148-154.
15. Gallego-Rojo FJ, Gonzalez-Calvin JL, Munoz-Torres M, Mundi JL, Fernandez-Perez R, Rodrigo-Moreno D. Bone mineral density, serum insulin like growth factor I, and bone turnover markers in viral cirrhosis. Hepatology 1998;28:695-699.
16. Ninkovic M, Love SA, Tom B, Alexander GJM, Compton JE. High prevalence of osteoporosis in patients with chronic liver disease prior to liver transplantation. Calcif Tissue Int 2001;69: 321-326.
17. Ormarsdottir S, Ljunggren O, Mallmin H, Brahm H, Loof L. Low body mass index and use of corticosteroids, but not cholestasis, are risk factors for osteoporosis in patients with chronic liver disease. J Hepatol 1999;31:84-90.
18. Guanabens N, Pares A, Marinoso L, Brancos MA, Piera C, Serrano S, et al. Factors influencing the development of metabolic bone disease in primary biliary cirrhosis. Am J Gastroenterol 1990;85:1356-1362.
19. Olsson R, Mattsson LA, Obrant K, Mellstrom D. Estrogen-progestogen therapy for low bone mineral density in primary biliary cirrhosis. Liver 1999;19:188-192.
20. Crippin JS, Jorgenesen RA, Dickson ER, Lindor KD. Hepatic osteodystrophy in primary biliary cirrhosis: effects of medical treatment. Am J Gastroenterol 1994;89:47-50.
21. Wolfhagen FH, van Buuren HR, den Ouden JW, Hop WC, van Leeuwen JP, Schalm SW, et al. Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis. A prospective, controlled pilot study. J Hepatol 1997;26: 325-330.
22. Angulo P, Therneau TM, Jorgensen A, De Sotel CK, Egan KS, Dickson ER, et al. Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression. J Hepatol 1998;29:729-735.
23. Hay JE, Lindor KD, Wiesner RH, Dickson ER, Krom RA, LaRusso NF. The metabolic bone disease of primary sclerosing cholangitis. Hepatology 1991;14:257-261.
24. Hodgson SF, Dickson ER, Eastell R, Eriksen EF, Bryant SC, Riggs BL. Rates of cancellous bone remodeling and turnover in osteopenia associated with primary biliary cirrhosis. Bone 1993; 14:819-827.
25. Mitchison HC, Malcolm AJ, Bassendine MF, James OF. Metabolic bone disease in primary biliary cirrhosis at presentation. Gastroenterology 1988;94:463-470.
26. Stellon AJ, Davies A, Compston J, Williams R. Osteoporosis in chronic cholestatic liver disease. QJM 1985;57:783-790.
27. Van Berkum FN, Beukers R, Birkenhager JC, Kooij PP, Schalm SW, Pols HA. Bone mass in women with primary biliary cirrhosis: the relation with histological stage and the use of steroids. Gastroenterology 1990;99:1134-1139.